Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"".
- DOI
- 10.1016/j.jaad.2026.06.020
- Published
- 2026 Oct
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.06.020,
title = {Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"".},
author = {Nikolaou V and Koumprentziotis IA and Gerochristou M and Patsatsi A and Tsimpidakis A and Tsitlakidou A and Soura E and Kemanetzi C and Routsi E and Lazaridou E and Stratigos A and Apalla Z},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.06.020},
url = {https://doi.org/10.1016/j.jaad.2026.06.020}
}RIS
TY - JOUR TI - Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"". AU - Nikolaou V AU - Koumprentziotis IA AU - Gerochristou M AU - Patsatsi A AU - Tsimpidakis A AU - Tsitlakidou A AU - Soura E AU - Kemanetzi C AU - Routsi E AU - Lazaridou E AU - Stratigos A AU - Apalla Z PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.06.020 UR - https://doi.org/10.1016/j.jaad.2026.06.020 ER -
APA
V, N., IA, K., M, G., A, P., A, T., A, T., E, S., C, K., E, R., E, L., A, S., & Z, A. (2026). Response to Zou et al, "Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study"".. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.06.020
Source records
- pubmed · retrieved 2026-09-27T09:10:40.895Z